Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
JCI Insight
|
February 19, 2026
Sympathetic nerve-fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancer
Ariana L Sattler, Parham Diba, Kevin Hawthorne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 9, 2012
In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type mice
Nicole K Paulk, Karsten Wursthorn, Annelise Haft, et al.
Science Advances
|
July 5, 2023
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
Hyungsoo Kim, Yongmei Feng, Rabi Murad, et al.
The Journal of Clinical Investigation
|
November 26, 2019
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity
Tyler Risom, Xiaoyan Wang, Juan Liang, et al.
Molecular and Cellular Biology
|
June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma
Samantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Pharmaceutics
|
December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment
Vidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Genes & Development
|
May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stress
Gabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Nature Communications
|
November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
Amy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Nature Communications
|
September 13, 2023
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
Zinab O Doha, Xiaoyan Wang, Nicholas L Calistri, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model
Isabel A English, Patrick J Worth, Kevin Alexander MacPherson-Hawthorne, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
JCI Insight
|
February 19, 2026
Sympathetic nerve-fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancer
Ariana L Sattler, Parham Diba, Kevin Hawthorne, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 9, 2012
In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type mice
Nicole K Paulk, Karsten Wursthorn, Annelise Haft, et al.
Science Advances
|
July 5, 2023
Melanoma-intrinsic NR2F6 activity regulates antitumor immunity
Hyungsoo Kim, Yongmei Feng, Rabi Murad, et al.
The Journal of Clinical Investigation
|
November 26, 2019
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity
Tyler Risom, Xiaoyan Wang, Juan Liang, et al.
Molecular and Cellular Biology
|
June 15, 2022
The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma
Samantha Z Brown, Grace A McCarthy, James R Carroll, et al.
Pharmaceutics
|
December 23, 2023
Micelle-Formulated Juglone Effectively Targets Pancreatic Cancer and Remodels the Tumor Microenvironment
Vidhi M Shah, Syed Rizvi, Alexander Smith, et al.
Genes & Development
|
May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stress
Gabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Nature Communications
|
November 25, 2017
MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
Amy S Farrell, Meghan Morrison Joly, Brittany L Allen-Petersen, et al.
Nature Communications
|
September 13, 2023
MYC Deregulation and PTEN Loss Model Tumor and Stromal Heterogeneity of Aggressive Triple-Negative Breast Cancer
Zinab O Doha, Xiaoyan Wang, Nicholas L Calistri, et al.
Biorxiv : the Preprint Server for Biology
|
August 12, 2025
Myc and Kras cooperate in adult acinar cells to drive phenotypic heterogeneity, metastasis, and therapeutic resistance in a novel pancreatic cancer mouse model
Isabel A English, Patrick J Worth, Kevin Alexander MacPherson-Hawthorne, et al.
Page
of 5